The search for new pharmaceutical drugs by medicinal chemists relies on the synthesis of diverse compound libraries for biological testing. Of the reactions used for this purpose, those involving ...

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...

A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma. The agent is selectively absorbed by brain tumor cells, exhibits enhanced blood retention, ...

Boron agents termed GluBs, developed by Science Tokyo researchers, have overcome a key limitation in cancer therapy by entering tumor cells through a pathway that standard drugs cannot use. The GluBs ...